FI883136A7 - Foerfarande foer framstaellning av antivirala kompositioner innehaollande cyklodextrin. - Google Patents

Foerfarande foer framstaellning av antivirala kompositioner innehaollande cyklodextrin. Download PDF

Info

Publication number
FI883136A7
FI883136A7 FI883136A FI883136A FI883136A7 FI 883136 A7 FI883136 A7 FI 883136A7 FI 883136 A FI883136 A FI 883136A FI 883136 A FI883136 A FI 883136A FI 883136 A7 FI883136 A7 FI 883136A7
Authority
FI
Finland
Prior art keywords
cyklodextrin
antivirala
foerfarande foer
foer framstaellning
kompositioner
Prior art date
Application number
FI883136A
Other languages
English (en)
Finnish (fi)
Other versions
FI883136A0 (fi
Inventor
Jean Mesens
Koenraad J L M Andries
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI883136A0 publication Critical patent/FI883136A0/fi
Publication of FI883136A7 publication Critical patent/FI883136A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI883136A 1987-07-01 1988-06-30 Foerfarande foer framstaellning av antivirala kompositioner innehaollande cyklodextrin. FI883136A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6851287A 1987-07-01 1987-07-01

Publications (2)

Publication Number Publication Date
FI883136A0 FI883136A0 (fi) 1988-06-30
FI883136A7 true FI883136A7 (fi) 1989-01-02

Family

ID=22083057

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883136A FI883136A7 (fi) 1987-07-01 1988-06-30 Foerfarande foer framstaellning av antivirala kompositioner innehaollande cyklodextrin.

Country Status (16)

Country Link
US (1) US4956351A (de)
EP (1) EP0300526A3 (de)
JP (1) JPS6445319A (de)
KR (1) KR890001554A (de)
AU (1) AU611692B2 (de)
CA (1) CA1322172C (de)
DK (1) DK360988A (de)
FI (1) FI883136A7 (de)
HU (1) HU204705B (de)
IL (1) IL86910A0 (de)
NO (1) NO882926L (de)
NZ (1) NZ225045A (de)
PH (1) PH26159A (de)
PT (1) PT87880A (de)
RU (1) RU2016567C1 (de)
ZA (1) ZA884747B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
WO1991004026A1 (en) * 1989-09-14 1991-04-04 Australian Commercial Research & Development Limited Drug delivery compositions
JO1645B1 (en) * 1989-12-26 1991-11-27 شركة جانسين فارماسوتيكا ان. في Pyridazine compounds are antibacterial viruses
GB9012663D0 (en) * 1990-06-07 1990-08-01 Erba Carlo Spa Galenic formulations containing cyclodextrins
IL100856A (en) * 1991-02-15 1998-03-10 Janssen Pharmaceutica Nv (carboxyl) alkyloxyalkyl derivatives of cyclodextrins, their preparation and pharmaceutical compositions containing them
US5221669A (en) * 1991-04-19 1993-06-22 The United States Of America As Represented By The Department Of Health And Human Services Antiviral compositions containing α-cyclodextrin sulfates alone and in combination with other known antiviral agents and glucocorticoids and methods of treating viral infections
US5321014A (en) * 1991-06-28 1994-06-14 The United States Of America As Represented By The Department Of Health And Human Services Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
DE4204315A1 (de) * 1992-02-13 1993-08-19 Consortium Elektrochem Ind Cyclodextringlycoside und verfahren zu ihrer herstellung
JPH08503951A (ja) * 1992-12-02 1996-04-30 インサイト・ビジョン・インコーポレイテッド シクロデキストリンとポリマーを用いた薬剤供給系
JP2787539B2 (ja) * 1993-02-26 1998-08-20 松森  昭 ウイルス性疾患の予防または治療剤
DE4333598A1 (de) * 1993-10-01 1995-04-06 Consortium Elektrochem Ind Verfahren zur Herstellung von alkylierten Cyclodextrin-Derivaten, nach dem Verfahren herstellbare methylierte Cyclodextrin-Derivate und die Verwendung der Produkte
EP0709099A3 (de) 1994-09-28 1996-07-24 Senju Pharma Co Wässrige Suspension zur nasalen Verabreichung enthaltend Cyclodextrin
WO1997039761A1 (en) 1996-04-19 1997-10-30 Alpha Therapeutic Corporation A process for viral inactivation of lyophilized blood proteins
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
AUPQ105499A0 (en) 1999-06-18 1999-07-08 Biota Scientific Management Pty Ltd Antiviral agents
US6479467B1 (en) * 1999-12-16 2002-11-12 Eastman Chemical Company Cyclodextrin ethers
AUPR213700A0 (en) 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
DE10203999A1 (de) * 2002-02-01 2003-08-14 Nutricia Nv Cycloglycane
WO2003080080A1 (en) * 2002-03-21 2003-10-02 Regents Of The University Of Minnesota Cyclodextrin compositions and methods of treating viral infections
WO2004078115A2 (en) * 2003-02-28 2004-09-16 Viropharma, Incorporated Benzothiazole compounds, compositions and methods for treatment and prophylaxis of rotavirus infections and associated diseases
CN101084207A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途
EP1807085B1 (de) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterozyklische Derivate und ihre Verwendung als Stearoyl-Coa-Desaturase-Inhibitoren
CN101084212A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
CA2580857A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
AU2005286793A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
WO2006034279A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
JP5149009B2 (ja) 2004-09-20 2013-02-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド ヒトステアロイル−CoAデサチュラーゼを阻害するためのピリダジン誘導体
EP2325171B1 (de) 2005-05-26 2013-10-09 Aldexa Therapeutics, Inc. Chinolinderivate zur Behandlung retinaler Erkrankungen
AU2006343359A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
US8158609B1 (en) * 2006-11-02 2012-04-17 Novartis Ag Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
US9814701B2 (en) 2009-12-11 2017-11-14 Aldeyra Therapeutics, Inc. Compositions and methods for the treatment of macular degeneration
RU2448120C1 (ru) * 2010-11-01 2012-04-20 Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" Клатратные комплексы бета-циклодекстрина с 1-{[6-бром-1-метил-5-метокси-2-фенилтиометил-1-н-индол-3-ил]карбонил}-4-бензилпиперазином, обладающие противовирусной активностью, их получение и применение
RU2451680C1 (ru) 2011-02-21 2012-05-27 Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство
RU2464042C1 (ru) * 2011-03-31 2012-10-20 Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" КЛАТРАТНЫЙ КОМПЛЕКС β-ЦИКЛОДЕКСТРИНА С ПРОИЗВОДНЫМ 5-ГИДРОКСИ-4-АМИНОМЕТИЛ-1-ЦИКЛОГЕКСИЛ(ИЛИ ЦИКЛОГЕПТИЛ)-3-АЛКОКСИКАРБОНИЛИНДОЛА, СПОСОБ ЕГО ПОЛУЧЕНИЯ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО
EP2948149B1 (de) 2013-01-23 2026-03-04 Aldeyra Therapeutics, Inc. Durch toxisches aldehyd bedingte erkrankungen und behandlung
EP4400106A1 (de) 2015-08-21 2024-07-17 Aldeyra Therapeutics, Inc. Deuterierte verbindungen und verwendungen davon
MX2018010292A (es) 2016-02-28 2018-09-27 Aldeyra Therapeutics Inc Tratamiento de condiciones oculares alergicas con ciclodextrinas.
EP3454858A4 (de) 2016-05-09 2020-01-15 Aldeyra Therapeutics, Inc. Kombinationsbehandlung von entzündlichen zuständen und erkrankungen des auges
CA3054811A1 (en) 2017-03-16 2018-09-20 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CA3077362A1 (en) 2017-10-10 2019-04-18 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
CN112714762A (zh) 2018-08-06 2021-04-27 奥尔德拉医疗公司 多晶型化合物及其用途
CA3113462A1 (en) 2018-09-25 2020-04-02 Aldeyra Therapeutics, Inc. Formulations of reproxalap for the treatment of dry eye disease
JP7706758B2 (ja) 2019-03-26 2025-07-14 アルデイラ セラピューティクス, インコーポレイテッド 眼科用製剤およびその使用
WO2020223717A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
JP2022530967A (ja) 2019-05-02 2022-07-05 アルデイラ セラピューティクス, インコーポレイテッド 多形化合物およびその使用
US12226431B2 (en) 2021-09-11 2025-02-18 Porosome Therapeutics, Inc. Aerosol and topical administration of a formulation containing cyclodextrin, quercetin and zinc, in combination or separately, to mitigate infection by enveloped viruses
JP2023526016A (ja) 2020-05-13 2023-06-20 アルデイラ セラピューティクス, インコーポレイテッド 医薬製剤およびその使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR64915B (en) * 1978-09-14 1980-06-09 Janssen Pharmaceutica Nv Improved etomidate-containing compositions
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition

Also Published As

Publication number Publication date
AU611692B2 (en) 1991-06-20
DK360988A (da) 1989-01-02
EP0300526A3 (de) 1989-04-12
NO882926D0 (no) 1988-06-30
HUT47433A (en) 1989-03-28
DK360988D0 (da) 1988-06-30
CA1322172C (en) 1993-09-14
RU2016567C1 (ru) 1994-07-30
PH26159A (en) 1992-03-18
NO882926L (no) 1989-01-02
ZA884747B (en) 1990-03-28
HU204705B (en) 1992-02-28
NZ225045A (en) 1990-06-26
KR890001554A (ko) 1989-03-27
IL86910A0 (en) 1988-11-30
PT87880A (pt) 1989-06-30
US4956351A (en) 1990-09-11
EP0300526A2 (de) 1989-01-25
AU1835288A (en) 1989-01-05
FI883136A0 (fi) 1988-06-30
JPS6445319A (en) 1989-02-17

Similar Documents

Publication Publication Date Title
FI872053A7 (fi) Foerfarande foer behandling av processgaser.
FI883136A0 (fi) Foerfarande foer framstaellning av antivirala kompositioner innehaollande cyklodextrin.
FI884335L (fi) Foerfarande foer framstaellning av laetta konstruktionsdelar.
FI871488A7 (fi) Fibreringsanordning foer framstaellning av mineralull.
FI872001L (fi) Anordning foer sammanfogning av tvao byggnadselement.
FI882732L (fi) Foerfarande foer framstaellning av baerarbundna enzymer.
FI870360A0 (fi) Nytt foerfarande foer framstaellning av natriumkarboximetylcellulosa.
FI870963L (fi) Foerfarande foer plantering av plantor.
FI883548A0 (fi) Avskiljare foer avskiljande av tobaksbestaondsdelar fraon en tobaks/gasblandning.
FI870122A0 (fi) Konjugat av biologiska molekyler.
FI870820A0 (fi) Foerfarande foer fraktionering av avlutar fraon alkaliska massakok.
FI871566A0 (fi) Regleringsanordning foer ytbehandlingsanordning av materialbana.
FI871386A0 (fi) Foerfarande foer framstaellning av kompositprodukter.
FI872170A0 (fi) Anordning foer laosande av en flygeldoerr.
FI871153A0 (fi) Anordning foer vertikalkvistning av traed.
FI870229L (fi) Anordning foer bestaemning av en pappersmassas filtreringsfoermaoga.
FI870385L (fi) Anordning foer rengoering av byggnadsytor medelst sandblaestring.
FI871149A0 (fi) Foerfarande foer ytbehandling av bildroer foer avlaegsning av statisk elektricitet.
FI871783L (fi) Foerfarande foer avlaegsnande av latenta egenskaper.
FI870396A0 (fi) Anordning foer foerbaettring av styrning av larvmatta.
FI871519A0 (fi) Foerfarande foer framstaellning av en dryck.
FI871008A0 (fi) Anordning foer matning av djur.
FI870075A0 (fi) Fyllnings- och brytningsanordning foer en av plastfolie omgiven plantklimp.
FI871797A0 (fi) Foerfarande foer gjutning av skalyta.
FI871007A0 (fi) Anordning foer uppsamling av olja fraon havet.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: JANSSEN PHARMACEUTICA N.V.